Paperonium

Breast cancer · JAMA Netw Open · 2025

Summary: on hormone therapy, overweight women’s breast-cancer risk is 1.40×. That’s obese women’s figure; theirs: 2.18×.

Summary: overweight womenResults: obese women, kind A,the summary’s figureResults: overweight women,kind AResults: overweight women,kind B1.83 times as likely1.40×1.021.922.18×1.832.611.322.551×1.5×2×3×same as non-usersmore likely
Summary:overweight womenResults: obesewomen, kind A, thesummary’s figureResults:overweightwomen, kind AResults:overweightwomen, kind B1.83 times as likely1.40×1.021.922.18×1.83 to 2.611.322.551×1.5×2×3×same as non-usersmore likely

Times as likely to get breast cancer on hormone therapy, with likely ranges

The paper says

Women past menopause on estrogen-plus-progestin therapy are more likely than non-users to get two kinds of breast cancer (call them A and B). The summary: healthy weight, 2.51 times as likely (A) and 1.95 (B); overweight, 1.40; obese, 1.68, kind not named.

Its own data show

The paper’s results and supplement list each kind separately. The summary’s overweight figure, 1.40 (range 1.02 to 1.92, where the true value likely lies), is exactly obese women’s figure for A; its obese 1.68 is obese women’s for B. Overweight women’s own figures, 2.18 (A) and 1.83 (B), appear nowhere in the summary.

“1.40 times as likely” means 40% more likely; 2.18 means 118% more. Most readers see just the summary. There, overweight women see about a third (40 of 118) of their extra risk of kind A, and risk seems to rise from overweight to obese. In the results it falls with weight for both kinds (A: 2.51, 2.18, 1.40).

“The summary” means the paper’s abstract: the short summary printed at its top, which is the part most readers see.

Read the paper →Full technical write-up →

Exogenous Hormones, Tumor Intrinsic Subtypes, and Breast Cancer · JAMA Netw Open (2025) · doi:10.1001/jamanetworkopen.2025.19236